377740 Stock Chart & Stats
₩4405.00
-₩225.00(-4.86%)
―
--
Day’s Range― - ―
52-Week Range₩4,240.00 - ₩6,320.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)79.98K
Market Cap
₩466.46B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.08
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding101,886,050
10 Day Avg. Volume84,225
30 Day Avg. Volume79,985
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)452,276.06
Revenue Forecast (FY)₩10.00T>
377740 FAQ
What was BioNote, Inc.’s price range in the past 12 months?
BioNote, Inc. lowest stock price was ₩4240.00 and its highest was ₩6320.00 in the past 12 months.
What is BioNote, Inc.’s market cap?
BioNote, Inc.’s market cap is ₩466.46B.
When is BioNote, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BioNote, Inc.’s earnings last quarter?
BioNote, Inc. released its earnings results on May 13, 2026. The company reported ₩410.821 earnings per share for the quarter, beating the consensus estimate of N/A by ₩410.821.
Is BioNote, Inc. overvalued?
According to Wall Street analysts BioNote, Inc.’s price is currently Undervalued.
Does BioNote, Inc. pay dividends?
BioNote, Inc. does not currently pay dividends.
What is BioNote, Inc.’s EPS estimate?
BioNote, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioNote, Inc. have?
BioNote, Inc. has 101,886,050 shares outstanding.
What happened to BioNote, Inc.’s price movement after its last earnings report?
BioNote, Inc. reported an EPS of ₩410.821 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.279%.
Which hedge fund is a major shareholder of BioNote, Inc.?
Currently, no hedge funds are holding shares in KR:377740
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
i-SENS, Inc.
―
AbClon, Inc.
―
Inventage Lab, Inc.
―
Aprilbio Co., Ltd.
―
TOMOCUBE, Inc.
―